Most research exists on each compound independently
Sources View all sources Diani AR et al
Additionally, with equivocal findings in DR and NAION, discussing personalized ocular risk of starting GLP-1RA in patients is key, and considering increased follow-up frequency after medication initiation may be warranted
Find out which supplements should be taken with food, including vitamins A, D, E, and K, fish oil, and CoQ10
for example, Lilly expects to share Phase 3 obesity data on orfoglipron, an oral GLP-1 agonist, and retatrutide, a triple agonist of GLP/GIP/glucagon receptors in 2025 3 Xie, Y., Choi, T., & Al-Aly, Z
LincNutri says the testing program is part of a broader commitment to quality that applies across its supplement line